Brief Research Report

Published on 17 May 2024

Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity

in Vaccines and Molecular Therapeutics

Ann Marie Stanley
Anastasia A. Aksyuk
Deidre Wilkins
Justin A. Green
Dongmei Lan
Kathryn Shoemaker
Hong-Van Tieu
Magdalena E. Sobieszczyk
Ann R. Falsey
Elizabeth J. Kelly

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401728

Original Research

Published on 17 May 2024

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

in Vaccines and Molecular Therapeutics

Natalie Kogseder
Viktoria Puxkandl
Wolfram Hoetzenecker
Sabine Altrichter

Frontiers in Immunology

doi 10.3389/fimmu.2024.1324987

Review

Published on 17 May 2024

Single domain antibodies from camelids in the treatment of microbial infections

in Vaccines and Molecular Therapeutics

Henri De Greve
Antonella Fioravanti

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334829

Original Research

Published on 15 May 2024

Tissue-specific sex differences in pediatric and adult immune cell composition and function

in Vaccines and Molecular Therapeutics

Mahina Tabassum Mitul
Jenna M. Kastenschmidt
Suhas Sureshchandra
Zachary W. Wagoner
Andrew M. Sorn
David R. Mcllwain
Jenny E. Hernandez-Davies
Aarti Jain
Rafael de Assis
Douglas Trask

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373537

172 views

Original Research

Published on 15 May 2024

Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response

in Vaccines and Molecular Therapeutics

Ryan Baker
Rebecca Lawlor
Maeve Smith
Jessica Price
Ashley Eaton
Andrew Lover
Dominique Alfandari
Peter Reinhart
Kathleen F. Arcaro
Barbara A. Osborne

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401209

268 views

Original Research

Published on 15 May 2024

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

in Vaccines and Molecular Therapeutics

Daniela Rivera-Pérez
Constanza Méndez
Benjamín Diethelm-Varela
Felipe Melo-González
Yaneisi Vázquez
Xing Meng
Qianqian Xin
Rodrigo A. Fasce
Jorge Fernández
Judith Mora

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372193

291 views

Original Research

Published on 14 May 2024

Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells

in Vaccines and Molecular Therapeutics

Kilian A. Wietschel
Kevin Fechtner
Elmer Antileo
Goran Abdurrahman
Chiara A. Drechsler
Michelle Kudzayi Makuvise
Ruben Rose
Mathias Voß
Andi Krumbholz
Stephan Michalik

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382911

432 views

Original Research

Published on 14 May 2024

Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina

in Vaccines and Molecular Therapeutics

Arnulfo Garza-Silva
Diego Rivera-Salinas
Andrea Rivera-Cavazos
Iván Francisco Fernández-Chau
Andrea Belinda Cepeda-Medina
Devany Paola Morales-Rodríguez
Irene Antonieta Barco-Flores
Miguel Ángel Sanz-Sánchez
Cecilia Acciardi
Graciela Paez-Bo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403784

218 views

Original Research

Accepted on 13 May 2024

MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus in vitro

in Vaccines and Molecular Therapeutics

Cheng Xu
Amr Ahmed Abdelrahim Gamil
Xiaolin Wang
Hetron M. Munang'andu
Oystein Evensen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401086

Original Research

Accepted on 13 May 2024

The cytoskeletal protein profilin is an important allergen in saltwort (Salsola kali)

in Vaccines and Molecular Therapeutics

Ludmila Peterkova
Pia Gattinger
Daria Trifonova
Margarete Focke-Tejkl
Victoria Garib
Nigora Magbulova
Gulnara Djambekova
Nodira Zakhidova
Mokhigul Ismatova
Bulent Enis Sekerel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379833

Original Research

Published on 13 May 2024

Polish regulatory system regarding ATMP hospital exemptions

in Vaccines and Molecular Therapeutics

Jan Pachocki
Frances Verter

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379134

257 views

Brief Research Report

Published on 13 May 2024

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis

in Vaccines and Molecular Therapeutics

Eliel Nham
Jang Wook Sohn
Won Suk Choi
Seong-Heon Wie
Jacob Lee
Jin-Soo Lee
Hye Won Jeong
Joong Sik Eom
Yu Jung Choi
Hye Seong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382944

372 views

Original Research

Accepted on 10 May 2024

Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated Individuals

in Vaccines and Molecular Therapeutics

Alejandro Torres-Flores
Luis Alberto Ontiveros-Padilla
Ruth Lizzeth Madera-Sandoval
Araceli Tepale Segura
Julian A. Gajón
Tania Rivera-Hernandez
Eduardo Antonio Ferat Osorio
Arturo Cérbulo-Vázquez
Lourdes Andrea Arriaga-Pizano
Laura C Bonifaz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394114

Original Research

Published on 10 May 2024

Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine

in Vaccines and Molecular Therapeutics

Alaa Karkashan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395870

203 views

Original Research

Published on 10 May 2024

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates

in Vaccines and Molecular Therapeutics

Marco Polo Peralta Alvarez
Holly Jones
Hugo Redondo Azema
Chloe Davis
Andrew D. White
Charlotte Sarfas
Mike Dennis
Shuailin Li
Daniel Wright
Eugenia Puentes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387454

343 views

Original Research

Published on 10 May 2024

A TLR4 ligand-based adjuvant for promoting the immunogenicity of typhoid subunit vaccines

in Vaccines and Molecular Therapeutics

Kishore R. Alugupalli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383476

236 views

Navigation group

Articles

Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

Single domain antibodies from camelids in the treatment of microbial infections

Tissue-specific sex differences in pediatric and adult immune cell composition and function

Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells

Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina

MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus in vitro

The cytoskeletal protein profilin is an important allergen in saltwort (Salsola kali)

Polish regulatory system regarding ATMP hospital exemptions

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis

Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated Individuals

Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates

A TLR4 ligand-based adjuvant for promoting the immunogenicity of typhoid subunit vaccines